Pyrrolopyrimidine derivatives having pharmacological activity

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/505 (2006.01)

Patent

CA 2148324

The invention relates to the use of the compounds mentioned below in the therapeutic treatment of tumour diseases and other proliferative diseases, such as psoriasis, and to novel compounds of that type. The compounds are compounds of formula I Image (I) wherein n is from 0 to 5 and, when n is not 0, R is one or more substituents selected from halogen, alkyl, trifluoromethyl and alkoxy; and R1 and R2 are each independently of the other alkyl, or phenyl that is unsubstituted or substituted by halogen, trifluoromethyl, alkyl or by alkoxy, it also being possible for one of the two radicals R1 and R2 to be hydrogen, or R1 and R2 together form an alkylene chain having from 2 to 5 carbon atoms that is unsubstituted or substituted by alkyl; or salts thereof. Compounds of formula I inhibit protein kinases, for example the tyrosine protein kinase of the receptor for the epidermal growth factor, EGF.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrolopyrimidine derivatives having pharmacological activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolopyrimidine derivatives having pharmacological activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyrimidine derivatives having pharmacological activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1720122

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.